🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Recruitingn/aAges 18 Years - anyAllHellenic Cooperative Oncology Group
NCT07723261 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is multicenter, prospective, open label, non-interventional study that will collect real-world data (RWD) on the clinical efficacy and safety of NalIriFOx as a first-line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with histologically or cytologically proven metastatic PDAC * 1st line treatment with NalIriFOx according to physician's choice * Patients willing to provide a Written Informed Consent Exclusion Criteria: * Patients not matching the above-mentioned inclusion criteria * Neoadjuvant or adjuvant treatment within 6 months from enrolment * Prior treatment with Liposomal irinotecan * Prior treatment of pancreatic cancer in the metastatic setting with chemotherapy or investigational therapy
💊

What it tests

  • Not listed
📍

Where

9 sites
Attikon University General Hospital
Athens, Greece
General Oncology Hospital Agioi Anargyroi
Athens, Greece
HYGEIA Hospital
Athens, Greece
HYGEIA Hospital
Athens, Greece
2nd Oncology Department, Metropolitan Hospital
Athens, Greece
Ippokratio
Athens, Greece
Larissa University General Hospital
Larissa, Greece
General Hospital Agios Andreas
Pátrai, Greece

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy